Syvart Dennen

2PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 27, 2025
Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma.

Syvart Dennen, Marty Masek, Paul Cockrum

|Jul 19, 2021
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist.

Syvart Dennen, Oliver Díaz Espinosa, Kelly Birch

Pageof 1

Frequent Collaborators

1 joint publications

Kelly Birch